Prevention of spontaneous mammary adenocarcinoma in HER-2/neu transgenic mice by foreign DNA

FASEB Journal

Volumn 16, Issue 13, 2002, Pages 1749-1754

  Sfondrini, Lucia ^a   Besusso, Dario ^a   Rumio, Cristiano ^b   Rodolfo, Monica ^a   Ménard, Sylvie ^a   Balsari, Andrea ^a,b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

CpG oligodeoxynucleotides; Danger signal; Innate immunity; Murine tumors

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; OLIGODEOXYNUCLEOTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CANCER PREVENTION; CONTROLLED STUDY; CPG ISLAND; FEMALE; GENE THERAPY; IMMUNE SYSTEM; IMMUNOSTIMULATION; INJECTION; LUNG METASTASIS; MOUSE; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR GROWTH; TUMOR IMMUNITY;

ADENOCARCINOMA; ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL DIVISION; FEMALE; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; OLIGODEOXYRIBONUCLEOTIDES; RATS; RECEPTOR, ERBB-2; TIME FACTORS; TUMOR CELLS, CULTURED;

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 0036845536     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.02-0383com     Document Type: Article

References (32)

1. Matzinger, P. (1994) Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045
2. Yamamoto, S., Yamamoto, T., Kataoka, T., Kuramoto, E., Yano, O., and Tokunaga, T. (1992) Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J. Immunol. 148, 4072-4076
3. Krieg, A. M., Love-Homan, L., Yi, A. K., and Harty, J. T. (1998) CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J. Immunol. 161, 2428-2434
4. Sun, S., Beard, C., Jaenisch, R., Jones, P., and Sprent, J. (1997) Mitogenicity of DNA from different organisms for murine B cells. J. Immunol. 159, 3119-3125
5. Krieg, A. M., Yi, A. K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., and Klinman, D. M. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (London) 374, 546-549
6. Ballas, Z. K., Rasmussen, W. L., and Krieg, A. M. (1996) Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157, 1840-1845
7. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., and Akira, S. (2000) A Toll-like receptor recognizes bacterial DNA. Nature (London) 408, 740-745
8. Kim, J. J., Trivedi, N. N., Nottingham, L. K., Morrison, L., Tsai, A., Hu, Y., Mahalingam, S., Dang, K., Ahn, L., Doyle, N. K., Wilson, D. M., Chattergoon, M. A., Chalian, A. A., Boyer, J. D., Agadjanyan, M. G., and Weiner, D. B. (1998) Modulation of amplitude and direction of in vivo immune responses by coadministration of cytokine gene expression cassettes with DNA immunogens. Eur. J. Immunol. 28, 1089-1103
9. Zimmermann, S., Egeter, O., Hausmann, S., Lipford, G. B., Rocken, M., Wagner, H., and Heeg, K. (1998) CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J. Immunol. 160, 3627-3630
10. Elkins, K. L., Rhinehart-Jones, T. R., Stibitz, S., Conover, J. S., and Klinman, D. M. (1999) Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J. Immunol. 162, 2291-2298
11. Klinman, D. M., Verthelyi, D., Takeshita, F., and Ishii, K. J. (1999) Immune recognition of foreign DNA: A cure for bioterrorism? Immunity 11, 123-129
12. Carpentier, A. F., Chen, L., Maltonti, F., and Delattre, J. Y. (1999) Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice. Cancer Res. 59, 5429-5432
13. Hafner, M., Zawatzky, R., Hirtreiter, C., Buurman, W. A., Echtenacher, B., Hehlgans, T. and Mannel, D. N. (2001) Antimetastatic effect of CpG DNA mediated by type I IFN. Cancer Res. 61, 5523-5528
14. Sfondrini, L., Besusso, D., Zoia, M. T., Rodolfo, M., Invernizzi, A. M., Taniguchi, M., Nakayama, T., Colombo, M. P., Ménard, S., and Balsari, A. (2002) The absence of CD1 molecule up-regulates the antitumor activity induced by CpG oligodeoxynucleotides in mice. J. Immunol. 169, 151-158
15. Wickstrom, E. (1997) Antisense c-myc inhibition of lymphoma growth. Antisense Nucleic Acid. Drug Dev. 7, 225-228
16. Smith, J. B., and Wickstrom, E. (1998) Antisense c-myc and immunostimulatory oligonucleotide inhibition of tumorigenesis in a murine B-cell lymphoma transplant model. J. Natl. Cancer Inst. 90, 1146-1154
17. Guy, C. T., Webster, M. A., Schaller, M., Parsons, T. J., Cardiff, R. D., and Muller, W. J. (1992) Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. USA 89, 10578-10582
18. Reilly, R. T., Gottlieb, M. B., Ercolini, A. M., Machiels, J. P., Kane, C. E., Okoye, F. I., Muller, W. J., Dixon, K. H., and Jaffee, E. M. (2000) HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice. Cancer Res. 60, 3569-3576
19. Lipford, G. B., Sparwasser, T., Bauer, M., Zimmermann, S., Koch, E. S., Heeg, K., and Wagner, H. (1997) Immunostimulatory DNA: Sequence-dependent production of potentially harmful or useful cytokines. Eur. J. Immunol. 27, 3420-3426
20. Sfondrini, L., Morelli, D., Ménard, S., Maier, J. A. M., Singh, M., Melani, C., Terrazzini, N., Colombo, M. P., Colnaghi, M. I., and Balsari, A. (1998) Anti-tumor immunity induced by murine melanoma cells transduced with the mycobacterium tuberculosis gene encoding the 38 kDa antigen. Gene Ther. 5, 247-252
21. Esserman, L.J., Lopez, T., Montes, R., Bald, L. N., Fendly, B. M., and Campbell, M.J. (1999) Vaccination with the extracellular domain of p185neu prevents mammary tumor development in neu transgenic mice. Cancer Immunol. Immunother. 47, 337-342
22. Amici, A., Venanzi, F. M., and Concetti, A. (1998) Genetic immunization against neu/erbB2 transgenic breast cancer. Cancer Immunol. Immunother. 47, 183-190
23. Sfondrini, L., Rodolfo, M., Singh, M., Colombo, M. P., Colnaghi, M. I., Ménard, S., and Balsari, A. (2000) Cooperative effects of Mycobacterium tuberculosis Ag38 gene transduction and IL-12 in vaccination against spontaneous tumor development in proto-neu-transgenic mice. Cancer Res. 60, 3777-3781
24. Pupa, S. M., Invernizzi, A. M., Forti, S., Nanni, P., Lollini, P. L., Meazza, R., Ferrini, S., and Ménard, S. (2001) Prevention of neu-expressing breast tumor development in mice transgenic for rat proto-neu by DNA vaccination. Gene Ther. 8, 75-79
25. Boggio, K., Nicoletti, G., Di Carlo, E., Cavallo, F., Landuzzi, L., Melani, C., Giovarelli, M., Rossi, I., Nanni, P., De Giovanni, C., Bouchard, P., Wolf, S., Modesti, A., Musiani, P., Lollini, P. L., Colombo, M. P., and Forni, G. (1998) Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J. Exp. Med. 188, 589-596
26. Ménard, S., Aiello, P., Tagliabue, E., Rumio, C., Lollini, P. L., Colnaghi, M. I., and Balsari, A. (2000) Tamoxifen chemoprevention of a hormone-independent tumor in the proto-neutransgenic mice model. Cancer Res. 60, 273-275
27. Di Carlo, E., Rovero, S., Boggio, K., Quaglino, E., Amici, A., Smorlesi, A., Forni, G., and Musiani, P. (2001) Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice. Clin. Cancer Res. 7, 830s-837s
28. Akira, S. (2001) Toll-like receptors and innate immunity. Adv. Immunol. 78, 1-56
29. Sparwasser, T., Koch, E. S., Vabulas, R. M., Heeg, K., Lipford, G. B., Ellwart, J. W., and Wagner, H. (1998) Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28, 2045-2054
30. Jakob, T., Walker, P. S., Krieg, A. M., Udey, M. C., and Vogel, J. C. (1998) Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161, 3042-3049
31. Hartmann, G., Weiner, G. J., and Krieg, A. M. (1999) CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl. Acad. Sci. USA 96, 9305-9310
32. Kawarada, Y., Ganss, R., Garbi, N., Sacher, T., Arnold, B., and Hammerling, G. J. (2001) NK- and CD8(+) T cell-mediated eradication of established tumors by peritumoral injection of CPG-containing oligodeoxynucleotides. J. Immunol. 167, 5247-5253